Found 67 results
Filters: Author is Kretzler, Matthias  [Clear All Filters]
2013
Merscher-Gomez S, Guzman J, Pedigo CE, Lehto M, Aguillon-Prada R, Mendez A, Lassenius MI, Forsblom C, Yoo T, Villarreal R et al..  2013.  Cyclodextrin protects podocytes in diabetic kidney disease.. Diabetes. 62(11):3817-27.
Ju W, Greene CS, Eichinger F, Nair V, Hodgin JB, Bitzer M, Lee Y-S, Zhu Q, Kehata M, Li M et al..  2013.  Defining cell-type specificity at the transcriptional level in human disease.. Genome Res. 23(11):1862-73.
Gadegbeku CA, Gipson DS, Holzman LB, Ojo AO, Song PXK, Barisoni L, Sampson MG, Kopp JB, Lemley KV, Nelson PJ et al..  2013.  Design of the Nephrotic Syndrome Study Network (NEPTUNE) to evaluate primary glomerular nephropathy by a multidisciplinary approach.. Kidney Int. 83(4):749-56.
Blattner SM, Hodgin JB, Nishio M, Wylie SA, Saha J, Soofi AA, Vining C, Randolph A, Herbach N, Wanke R et al..  2013.  Divergent functions of the Rho GTPases Rac1 and Cdc42 in podocyte injury.. Kidney Int. 84(5):920-30.
Sanchez-Niño MDolores, Poveda J, Sanz ABelen, Mezzano S, Carrasco S, Fernandez-Fernandez B, Burkly LC, Nair V, Kretzler M, Hodgin JB et al..  2013.  Fn14 in podocytes and proteinuric kidney disease.. Biochim Biophys Acta. 1832(12):2232-43.
Martini S, Nair V, Patel SR, Eichinger F, Nelson RG, E Weil J, Pezzolesi MG, Krolewski AS, Randolph A, Keller BJ et al..  2013.  From single nucleotide polymorphism to transcriptional mechanism: a model for FRMD3 in diabetic nephropathy.. Diabetes. 62(7):2605-12.
Sampson MG, Gillies CE, Ju W, Kretzler M, Kang HMin.  2013.  Gene-level integrated metric of negative selection (GIMS) prioritizes candidate genes for nephrotic syndrome.. PLoS One. 8(11):e81062.
Hodgin JB, Nair V, Zhang H, Randolph A, Harris RC, Nelson RG, E Weil J, Cavalcoli JD, Patel JM, Brosius FC et al..  2013.  Identification of cross-species shared transcriptional networks of diabetic nephropathy in human and mouse glomeruli.. Diabetes. 62(1):299-308.
Zhao W, Berthier CC, Lewis EE, W McCune J, Kretzler M, Kaplan MJ.  2013.  The peroxisome-proliferator activated receptor-γ agonist pioglitazone modulates aberrant T cell responses in systemic lupus erythematosus.. Clin Immunol. 149(1):119-32.
Eksi R, Li H-D, Menon R, Wen Y, Omenn GS, Kretzler M, Guan Y.  2013.  Systematically differentiating functions for alternatively spliced isoforms through integrating RNA-seq data.. PLoS Comput Biol. 9(11):e1003314.
Wanic K, Krolewski B, Ju W, Placha G, Niewczas MA, Walker W, Warram JH, Kretzler M, Krolewski AS.  2013.  Transcriptome analysis of proximal tubular cells (HK-2) exposed to urines of type 1 diabetes patients at risk of early progressive renal function decline.. PLoS One. 8(3):e57751.
2012
Berthier CC, Bethunaickan R, Gonzalez-Rivera T, Nair V, Ramanujam M, Zhang W, Böttinger EP, Segerer S, Lindenmeyer M, Cohen CD et al..  2012.  Cross-species transcriptional network analysis defines shared inflammatory responses in murine and human lupus nephritis.. J Immunol. 189(2):988-1001.
Keller BJ, Eichinger F, Kretzler M.  2012.  Formal concept analysis of disease similarity.. AMIA Jt Summits Transl Sci Proc. 2012:42-51.
Berthier CC, Kretzler M, Davidson A.  2012.  From the Large Scale Expression Analysis of Lupus Nephritis to Targeted Molecular Medicine.. J Data Mining Genomics Proteomics. 3(3)
Ju W, Smith S, Kretzler M.  2012.  Genomic biomarkers for chronic kidney disease.. Transl Res. 159(4):290-302.
El-Meanawy A, Schelling JR, Iyengar SK, Hayden P, Barathan S, Goddard K, Pozuelo F, Elashi E, Nair V, Kretzler M et al..  2012.  Identification of nephropathy candidate genes by comparing sclerosis-prone and sclerosis-resistant mouse strain kidney transcriptomes.. BMC Nephrol. 13:61.
Komorowsky CV, Brosius FC, Pennathur S, Kretzler M.  2012.  Perspectives on systems biology applications in diabetic kidney disease.. J Cardiovasc Transl Res. 5(4):491-508.

Pages